You are here

Article info

Article menu
Download PDFPDF
Value for money
Premedications for infliximab infusions do not impact the risk of acute adverse drug reactions

Authors

  1. Correspondence to Dr James Ducharme, 9-6400 Millcreek Drive, Mississauga, ON L5N 3E7, Canada; jducharme{at}aimhealthgroup.com
View Full Text

Citation

Ducharme J, Pelletier C, Zacharias R
Premedications for infliximab infusions do not impact the risk of acute adverse drug reactions
Frontline Gastroenterology 2011;2:249-254.

Publication history

  • Accepted June 30, 2011
  • First published August 11, 2011.
Online issue publication 
April 19, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions